发明申请
US20210101967A1 TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G
有权
基本信息:
- 专利标题： TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G
- 申请号：US17121553 申请日：2020-12-14
- 公开(公告)号：US20210101967A1 公开(公告)日：2021-04-08
- 发明人： William H. Frey, II , Leah Ranae Bresin Hanson , Sharon Pokropinski , Francisco M. Rausa, III
- 申请人： Baxalta Incorporated , Baxalta Incorporated
- 申请人地址： US IL Bannockburn; CH Glattpark (Opfikon)
- 专利权人： Baxalta Incorporated,Baxalta Incorporated
- 当前专利权人： Baxalta Incorporated,Baxalta Incorporated
- 当前专利权人地址： US IL Bannockburn; CH Glattpark (Opfikon)
- 主分类号： C07K16/18
- IPC分类号： C07K16/18 ; A61K31/198 ; A61K31/4172 ; A61K31/401 ; A61K9/00 ; C07K16/06
摘要：
The present invention provides, among other aspects, methods and compositions for treating a central nervous system (CNS) disorder by delivering a therapeutically effective amount of a composition of pooled human immunoglobulin G (IgG) to the brain via intranasal administration of the composition directly to the olfactory epithelium of the nasal cavity. In particular, methods and compositions for treating Alzheimer's disease are provided.
公开/授权文献:
IPC结构图谱:
| C | 化学；冶金 |
| --C07 | 有机化学 |
| ----C07K | 肽 |
| ------C07K16/00 | 免疫球蛋白，例如，单克隆或多克隆抗体 |
| --------C07K16/18 | .来自动物或人的抵抗物质 |